Brancaccio D - Search Results

1

Aluminum-dependent transfusions in dialysis.

Brancaccio D, Gallieni M, Anelli A, Padovese P. Brancaccio D, et al. Arch Intern Med. 1988 Oct;148(10):2299, 2302. doi: 10.1001/archinte.148.10.2299a. Arch Intern Med. 1988. PMID: 3178387 No abstract available.

2

Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.

Padovese P, Gallieni M, Galmozzi C, Brancaccio D. Padovese P, et al. Among authors: brancaccio d. Lancet. 1990 Jun 16;335(8703):1465. doi: 10.1016/0140-6736(90)91493-t. Lancet. 1990. PMID: 1972238 No abstract available.

3

Overt dialysis encephalopathy and mildly raised plasma aluminium.

Brancaccio D, Padovese P, Gallieni M, Anelli A, Lazzaroni M, Avanzini G. Brancaccio D, et al. Lancet. 1989 Sep 23;2(8665):736. doi: 10.1016/s0140-6736(89)90792-7. Lancet. 1989. PMID: 2570976 No abstract available.

4

Substitution of calcium carbonate for aluminum hydroxide in patients on hemodialysis. Effects on acidosis, on parathyroid function, and on calcemia.

Anelli A, Brancaccio D, Damasso R, Padovese P, Gallieni M, Garella S. Anelli A, et al. Among authors: brancaccio d. Nephron. 1989;52(2):125-32. doi: 10.1159/000185614. Nephron. 1989. PMID: 2500612

5

Indirect evidence for transfusion role in conditioning hepatitis C virus prevalence among dialysis patients.

Moroni GA, Cori P, Marelli F, Del Prete M, Padovese P, Gallieni M, Anelli A, Brancaccio D. Moroni GA, et al. Among authors: brancaccio d. Nephron. 1991;57(3):371-2. doi: 10.1159/000186292. Nephron. 1991. PMID: 1901962 Free article. No abstract available.

6

Desferrioxamine infusion can modify EEG tracing in haemodialysed patients.

Brancaccio D, Avanzini G, Padovese P, Gallieni M, Franceschetti S, Panzica F, Anelli A, Colantonio G, Martinelli D, Bugiani O. Brancaccio D, et al. Nephrol Dial Transplant. 1991;6(4):264-8. doi: 10.1093/ndt/6.4.264. Nephrol Dial Transplant. 1991. PMID: 1881580

7

Dialysis amyloidosis: clinical aspects and therapeutic approach.

Brancaccio D, Cozzolino M, Gallieni M. Brancaccio D, et al. Nephrol Dial Transplant. 1996;11 Suppl 3:102-5. doi: 10.1093/ndt/11.supp3.102. Nephrol Dial Transplant. 1996. PMID: 8840323 Review. No abstract available.

8

Beta-2-microglobulin amyloidosis and osteo-articular pathology of the uremic patient on regular dialysis.

Brancaccio D, Anelli A, Gallieni M, Padovese P, Coggi G, Uslenghi C. Brancaccio D, et al. Contrib Nephrol. 1990;77:177-86. doi: 10.1159/000418118. Contrib Nephrol. 1990. PMID: 2188786 Review. No abstract available.

9

Dialysis amyloidosis with massive popliteal deposition of beta 2-microglobulin amyloid.

Brancaccio D, Gallieni M, Padovese P, Anelli A, Coggi G, Uslenghi C. Brancaccio D, et al. Lancet. 1988 Oct 1;2(8614):802. doi: 10.1016/s0140-6736(88)92459-2. Lancet. 1988. PMID: 2901651 No abstract available.

10

Beta-2-microglobulin amyloidosis in uremic dialyzed patients.

Brancaccio D, Gallieni M, Padovese P, Anelli A. Brancaccio D, et al. Contrib Nephrol. 1989;70:202-7. doi: 10.1159/000416924. Contrib Nephrol. 1989. PMID: 2670429 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters